from the same period of last year due to loss on forward contract caused by foreign exchange volatility during the Covid-19 pandemic. 1.2 Cost of goods sold and expenses Consolidated financial statements
. The cost of medical treatments when compared to income from medical treatments decreased 5.06% due to the cost of medical treatments from CMR went down 9.00% and the cost of medical treatments in the
Director 5. Mrs. Warangkana Kalayanapradit Director 6. Mr. Ka Ming Jacky Lam Director 7. Mr. Apivut Thongkam Chairman of the Audit Committee and Independent Director 8. Mr. Chaiyasit Puvapiromquan
following revenue decline while maintaining FY22 guidance AIS continued to enhance operating efficiency while expanding 5G/4G to strengthen our network leadership, reflected in a muted increase in both cost
1.90 6.36 434.73 Total income 24.01 7.52 16.49 319.28 Cost of Media-advertising (4.57) - (4.57) (100.00) Cost of organizing concerts - (4.01) - - Selling cost (12.24) (1.19) (11.05) (1028.57) Total cost
during first half of 2017. However, the increasing in domestic sales push up the total revenue becoming minor decreasing. Cost of goods sold of Q3/17 is increased by 5.86% comparing with Q2/17 and 7.82
Operating results of the Company for the three-month period ended 31 March 2019 and 2018 are as follows: Revenue by segment Revenue Cost Gross Profit For three-month period ended 31 March For three-month
was stagnant, the food sales for Q2’2018 was Baht 1,607 million, increased by Baht 13 million or 0.8% from Q2’2017 mainly from continued store expansion. Cost of Sales Total cost of sales of the company
Details of the costs involving to the WTGs foundation improvement for Huay Bong 2&3 Wind Farm at September 30, 2017 are as shown in the table. Description Estimated total improvement cost (until year 2016
foundation improvement for Huay Bong 2&3 Wind Farm as at December 31, 2017 are as shown in the table. Description Estimated total improvement cost (as of year 2016) Estimate and cost for accounting recorded in